Safety profile of COVID-19 drugs in a real clinical setting
Author:
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Pharmacology,General Medicine
Link
https://link.springer.com/content/pdf/10.1007/s00228-021-03270-2.pdf
Reference95 articles.
1. Ven Venkatasubbaiah M, Reddy PD, Satyanarayana SV (2020) Literature-based review of the drugs used for the treatment of COVID-19. Current medicine research and practice 10(3):100–109. https://doi.org/10.1016/j.cmrp.2020.05.013
2. WHO (2021) W.H.O. WHO coronavirus (COVID-19) dashboard. https://covid19.who.int/. Accessed 14 June 2021
3. Singh TU, Parida S, Lingaraju MC et al (2020) Drug repurposing approach to fight COVID-19. Pharmacol Rep 72:1479–1508
4. Tarighi P, Eftekhari S, Chizari, et al (2021) A review of potential suggested drugs for coronavirus disease (COVID-19) treatment. Eur J Pharmacol 895:173890. https://doi.org/10.1016/j.ejphar.2021.173890
5. Crescioli G, Brilli V, Lanzi C et al (2021) Adverse drug reactions in SARS-CoV-2 hospitalised patients: a case-series with a focus on drug–drug interactions. Intern Emerg Med 16(3):697–710. https://doi.org/10.1007/s11739-020-02586-8
Cited by 18 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. New methods for resolution of hydroxychloroquine by forming diastereomeric salt and adding chiral mobile phase agent on RP‐HPLC;Chirality;2024-05
2. Favipiravir for treating COVID-19;Cochrane Database of Systematic Reviews;2024-02-05
3. Favipiravir Protects Enterocytes From Cell Death After Inflammatory Storm;Cureus;2023-10-21
4. Effects of Tocilizumab on Intervertebral Disc Degeneration, Cell Senescence and Inflammation via BMP-2, Hif-1α , IL-1β and SOX9;International Journal of Pharmacology;2023-08-01
5. Prenol, but Not Vitamin C, of Fruit Binds to SARS-CoV-2 Spike S1 to Inhibit Viral Entry: Implications for COVID-19;The Journal of Immunology;2023-05-05
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3